Dáil Éireann Debate, Tuesday - 11 October 2016
405. Deputy Michael Harty asked the Minister for Health the reason the drug Macushield is no longer on the list of drugs and appliances under the hardship scheme; and if he will make a statement on the matter. [29455/16]
Amharc ar fhreagraThe HSE has advised that Macushield products have never been made available to all persons with medical card eligibility; however, Macushield and similar products were historically available to medical card holders in many areas under Discretionary Hardship Arrangements.
In developing a national framework for the administration of Discretionary Hardship Arrangements, the HSE's Medicines Management Programme (MMP) was asked to review the available therapeutic evidence for supporting reimbursement of Macushield and similar products. The MMP report supported the view of the National Centre for Pharmacoeconomics that the evidence for dietary carotenoids for the prevention of age-related macular degeneration (AMD) is inconclusive, and the MMP therefore does not recommend that products containing these preparations be reimbursed under any community drug scheme.
In light of the MMP's published report, the HSE decided to cease reimbursement support for these products. The MMP report is available at: http://www.hse.ie/eng/about/Who/clinical/natclinprog/medicinemanagementprogramme/yourmedicines/Evaluation_Reports/.
